Welcome to our dedicated page for Careview Comm SEC filings (Ticker: CRVW), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
When you need to confirm how many hospital beds now stream live video through CareView’s patented monitoring network—or whether new FDA guidance could reshape future sales—the answers live inside the company’s SEC disclosures. Investors typically start with the CareView Communications annual report 10-K simplified to see recurring-revenue details, then drill into each CareView Communications quarterly earnings report 10-Q filing for updates on installed systems, margin shifts, and cash burn. But 200-plus pages of healthcare-tech jargon slow decision-making.
Stock Titan’s platform surfaces what matters in seconds. Our AI reads every document, tags risk wording, and delivers plain-English summaries—so understanding CareView Communications SEC documents with AI becomes straightforward. Real-time alerts flag each CareView Communications 8-K material events explained and push notices the moment a CareView Communications Form 4 insider transactions real-time posting appears. Need specifics? Open the interactive dashboard to compare R&D spend across years, scan revenue by hospital group, or bookmark sections on reimbursement risk. You’ll also find the full text whenever you want a deeper dive—complete coverage from 10-K, 10-Q, 8-K and S-1 to the CareView Communications proxy statement executive compensation.
Monitoring leadership confidence is easy, too. Our AI links each CareView Communications insider trading Form 4 transactions entry to share-price moves so you can gauge sentiment. For earnings season, the system highlights KPI trends and delivers concise CareView Communications earnings report filing analysis. Whether you’re tracking upcoming hospital network contracts or benchmarking patient-safety tech spending, Stock Titan turns labyrinthine filings into actionable insight. Finally, every document is archived, searchable, and exportable—giving you the clarity and speed professional investors expect.
CareView Communications (CRVW) filed its Q3 2025 10‑Q, showing modest top‑line growth and narrower losses alongside ongoing balance sheet pressure. Revenue for the quarter was $2,064,535 versus $1,932,382 a year ago, driven primarily by software recognized over time. Operating loss improved to $132,467 from $684,476, and net loss narrowed to $914,214 from $1,470,655. For the nine months, revenue reached $6,682,928 (vs. $6,109,259) with an operating loss of $68,406.
Liquidity remains tight. Cash was $1,731,276 as of September 30, 2025. The company reported a working capital deficit of $42,789,653 and a stockholders’ deficit of $42,391,690, and disclosed substantial doubt about continuing as a going concern. Notes payable totaled $20,700,000 with maturity extended to December 31, 2025; accrued interest payable was $22,094,014. Deferred revenue stood at $3,082,405, scheduled to be recognized over the next periods.
Cash provided by operating activities was $1,033,269 for the nine months, reflecting improved collections and deferred revenue activity while interest expense continued to weigh on results.
CareView Communications, Inc. filed a Form 8-K reporting the Twelfth Amendment to its credit agreement dated in the report as of September 30, 2025. The amendment lists the parties as the company (including a Texas corporate designation), PDL Investment Holdings, LLC, Steven G. Johnson, and Dr. James R. Higgins. The filing is signed by Steven G. Johnson, Chief Executive Officer, on October 2, 2025. The 8-K notice identifies the existence of the amendment but does not include the amendment's terms, financial amounts, or any changes to covenants or maturity dates within the disclosed text. Because the document provides only the amendment notice and parties, no additional financial or contractual details are available from this filing.
FAQ
What is the current stock price of Careview Comm (CRVW)?
What is the market cap of Careview Comm (CRVW)?
